Static measurements to determine rates of insulin secretion, glucagon secretion, and cAMP release Rates of insulin, glucagon, and cAMP release were determined statically under multiple conditions as previously described 82
What I saw in the trial data was that the strongest candidates shared these features: BMI of 30 or higher, or 27 or higher with a comorbidity Elevated fasting glucose or insulin resistance High triglycerides or low HDL cholesterol Elevated blood pressure Non-alcoholic fatty liver disease A history of struggling to maintain weight loss long-term These are not just checkboxes
Many patients continue making progress after reviewing their treatment plan, improving nutrition, increasing protein intake, adding resistance training, or adjusting medication under provider guidance
Devices should be intuitive enough to minimize challenges for visually impaired patients or those with dexterity issues, as self-administration with certain pens (e.g., KwikPens) is not recommended for these groups without assistance
Kramer, MD, FACC , et al., randomized 731 patients from 129 centers in nine countries to receive tirzepatide up to 15 mg subcutaneously weekly (n=364) or placebo (n=367) for a median of two years
with women, adolescents, and patients with psychiatric disorders being the most affected groups.4 There is currently no definitive cure for vitiligo